LivaNova PLC Ordinary Shares (LIVN) is a publicly traded Healthcare sector company. As of September 22, 2026, LIVN trades at $77.75 with a market cap of $4.30B and a P/E ratio of 22.70. LIVN moved +0.19% today. Year to date, LIVN is +27.04%; over the trailing twelve months it is +42.13%. Its 52-week range spans $32.48 to $85.76. Analyst consensus is strong buy with an average price target of $88.20. Rallies surfaces LIVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
LIVN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. LIVN recently traded at $77.75. Market cap is $4.30B. P/E ratio is 22.70. Revenue is $1.47B.
| Metric | Value |
|---|---|
| Price | $77.75 |
| Market Cap | $4.30B |
| P/E Ratio | 22.70 |
| EPS | $3.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.76 |
| 52-Week Low | $32.48 |
| Volume | 442.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.47B |
| Net Income | $188.55M |
| Gross Margin | 68.10% |
6 analysts cover LIVN: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $88.20.